The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment

Recruiting now · Not applicable

Conditions studied: Dry Eye

In brief

The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.

Key facts

Study ID

NCT06830551

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

10

Starts

2023-09-12

Expected to finish

2025-12-31

Last updated by the study team

2025-02-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age over 18 years
• oncology and advanced cancer patients who have EGFr mutation and who require treatment with antiEGFr drugs
• signing of informed consent

You may not qualify if…

• Patients who are unable to store/administer the CSCO independently, or with the help of care-givers.

Where it is running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.